Related Experiment Video
Updated: Jun 24, 2026

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model
Published on: September 9, 2011
Second-generation Amplatzer Vascular Plug (AVP) for the treatment of subsequent subclavian backflow type II endoleak
Carsten Meyer1, Chris Probst, Holger Strunk
1Department of Radiology, University of Bonn, Sigmund-Freud-Str. 25, 53129, Bonn, Germany.
Abstract:
Since its approval as an occlusive device in the peripheral vasculature in 2004, the first-generation Amplatzer Vascular Plug (AVP; AGA Medical, Golden Valley, MN, USA) has already become a therapeutic alternative to coil embolization in dedicated cases. Here, we present for the first time, a case of type II endoleak from the left subclavian artery after thoracic stent-graft placement successfully treated with a second-generation AVP.
Related Concept Videos
Hemodialysis I: Introduction
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Venous Thrombosis III: Interprofessional Care
